N
Narutoshi Hibino
Researcher at University of Chicago
Publications - 190
Citations - 6996
Narutoshi Hibino is an academic researcher from University of Chicago. The author has contributed to research in topics: Cardiac surgery & Inferior vena cava. The author has an hindex of 37, co-authored 177 publications receiving 5814 citations. Previous affiliations of Narutoshi Hibino include Boston Children's Hospital & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.
Toshiharu Shinoka,Goki Matsumura,Narutoshi Hibino,Yuji Naito,Manabu Watanabe,Takeshi Konuma,Takahiko Sakamoto,Masayoshi Nagatsu,Hiromi Kurosawa +8 more
TL;DR: Biodegradable conduits or patches seeded with autologous bone marrow cells showed normal function and the tissue-engineering approach may provide an important alternative to the use of prosthetic materials in the field of pediatric cardiovascular surgery.
Journal ArticleDOI
Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
Jason D. Roh,Rajendra Sawh-Martinez,Matthew P. Brennan,Steven M. Jay,Lesley Devine,Deepak A. Rao,Tai Yi,Tamar L. Mirensky,Ani Nalbandian,Brooks V. Udelsman,Narutoshi Hibino,Toshiharu Shinoka,W. Mark Saltzman,Edward L. Snyder,Themis R. Kyriakides,Jordan S. Pober,Christopher K. Breuer +16 more
TL;DR: Findings suggest TEVGs transform into functional neovessels via an inflammatory process of vascular remodeling in mice implanted with human BMC-seeded scaffolds.
Journal ArticleDOI
Late-term results of tissue-engineered vascular grafts in humans
Narutoshi Hibino,Edward A. McGillicuddy,Goki Matsumura,Yuki Ichihara,Yuji Naito,Christopher K. Breuer,Toshiharu Shinoka +6 more
TL;DR: Tissue-engineered vascular grafts can be used as conduits in patients with single ventricle physiology and further follow-up and investigation for the mechanism of stenosis are warranted.
Journal ArticleDOI
Successful application of tissue engineered vascular autografts: clinical experience.
TL;DR: Results indicate that BMCs seeded onto a biodegradable scaffold to establish tissue-engineered vascular autografts (TEVAs) is an ideal strategy, and present strong evidence for the justification and validity of the protocol in clinical trials of tissue engineering.
Journal ArticleDOI
Principles of the Kenzan Method for Robotic Cell Spheroid-Based Three-Dimensional Bioprinting*
TL;DR: The future of bioprinting may benefit from the use of gentler scaffold-free bioassembling methods, as a substantial body of evidence has accumulated, indicating this is possible by use of preformed cell spheroids, which have been assembled in cartilage.